An obesity paradox: an inverse correlation between body mass index and atherosclerosis of the aorta

Cardiovascular Pathology

Volumn 25, Issue 6, 2016, Pages 515-520

  Brodsky, Sergey V ^a   Barth, Rolf F ^a   Mo, Xiaokui ^a   Yildiz, Vedat ^a   Allenby, Patricia ^a   Ivanov, Iouri ^a   Moore, Stephen ^a   Hitchcock, Charles L ^a   Smith, Stephen ^a   Sachak, Taha ^a   Yao, Keluo ^a   Ball, Matthew ^a   Rosborough, Kelly ^a   Olson, Zachary ^a   Kiehl, Micah ^a   Muni, Navin ^a   Virmani, Renu ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b CVPATH INSTITUTE   (United States)

Author keywords

Aortic atherosclerosis; Body mass index (BMI); Obesity paradox

Indexed keywords

ADULT; AGE; AGED; AORTA ATHEROSCLEROSIS; ARTICLE; AUTOPSY; BODY MASS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART WEIGHT; HEIGHT; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; PRIORITY JOURNAL; PROBABILITY; RACE; AORTIC DISEASES; ATHEROSCLEROSIS; MIDDLE AGED; OBESITY, MORBID; YOUNG ADULT;

ADULT; AGED; AORTIC DISEASES; ATHEROSCLEROSIS; AUTOPSY; BODY MASS INDEX; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY, MORBID; YOUNG ADULT;

EID: 84988698707     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2016.09.002     Document Type: Article

References (40)

1. [1] Fleischmann, E., Teal, N., Dudley, J., May, W., Bower, J.D., Salahudeen, A.K., Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 55 (1999), 1560–1567.
2. [2] Schmidt, D.S., Salahudeen, A.K., Obesity-survival paradox-still a controversy?. Semin Dial 20 (2007), 486–492.
3. [3] Kalantar-Zadeh, K., Block, G., Humphreys, M.H., Kopple, J.D., Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63 (2003), 793–808.
4. [4] Kalantar-Zadeh, K., Block, G., Horwich, T., Fonarow, G.C., Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 43 (2004), 1439–1444.
5. [5] Gurm, H.S., Brennan, D.M., Booth, J., Tcheng, J.E., Lincoff, A.M., Topol, E.J., Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox). Am J Cardiol 90 (2002), 42–45.
6. [6] Oreopoulos, A., Padwal, R., Kalantar-Zadeh, K., Fonarow, G.C., Norris, C.M., McAlister, F.A., Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 156 (2008), 13–22.
7. [7] Lavie, C.J., Milani, R.V., Obesity and cardiovascular disease: the hippocrates paradox?. J Am Coll Cardiol 42 (2003), 677–679.
8. [8] Morkedal, B., Romundstad, P.R., Vatten, L.J., Mortality from ischaemic heart disease: age-specific effects of blood pressure stratified by body-mass index: the HUNT cohort study in Norway. J Epidemiol Community Health 65 (2011), 814–819.
9. [9] Health USDo, Human S, Protection of human subjects. Code of federal regulations 45: public welfare, 1995 [Title 45:Unknown].
10. [10] Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee World Health Organization technical report series, 854, 1995, 1–452.
11. [11] Fryar, C.D., Gu, Q., Ogden, C.L., Anthropometric reference data for children and adults: United States, 2007-2010. Vital and health statistics series 11, data from the national health survey, 2012, 1–48.
12. [12] Rissanen, V., Pyorala, K., Application of point-counting technique to the quantitative assessment of coronary and aortic atherosclerosis. Acta Pathol Microbiol Scand A Pathol 80 (1972), 412–420.
13. [13] Watanabe, S., Terazawa, K., Matoba, K., Age estimation from quantitative evaluation of atherosclerosis of abdominal aorta in Japanese. Hokkaido Igaku Zasshi 82 (2007), 91–98.
14. [14] Jen, K.Y., Olson, J.L., Brodsky, S., Zhou, X.J., Nadasdy, T., Laszik, Z.G., Reliability of whole slide images as a diagnostic modality for renal allograft biopsies. Hum Pathol 44 (2013), 888–894.
15. [15] Landis, J.R., Koch, G.G., The measurement of observer agreement for categorical data. Biometrics 33 (1977), 159–174.
16. [16] Zou, G., A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 159 (2004), 702–706.
17. [17] Spiegelman, D., Hertzmark, E., Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 162 (2005), 199–200.
18. [18] Pedersen, H.S., Mulvad, G., Newman, W.P., Boudreau, D.A., Atherosclerosis in coronary arteries and aorta among Greenlanders: an autopsy study. Atherosclerosis 170 (2003), 93–103.
19. [19] Castro-Anon, O., Perez de Llano, L.A., De la Fuente Sanchez, S., Golpe, R., Mendez Marote, L., Castro-Castro, J., et al. Obesity-hypoventilation syndrome: increased risk of death over sleep apnea syndrome. PloS One, 10, 2015, e0117808.
20. [20] Masa, J.F., Corral, J., Romero, A., Caballero, C., Teran-Santos, J., Alonso-Alvarez, M.L., et al. Protective cardiovascular effect of sleep apnea severity in obesity hypoventilation syndrome. Chest 150 (2016), 68–79.
21. [21] Degoulet, P., Legrain, M., Reach, I., Aime, F., Devries, C., Rojas, P., et al. Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron 31 (1982), 103–110.
22. [22] Ellis, S.G., Elliott, J., Horrigan, M., Raymond, R.E., Howell, G., Low-normal or excessive body mass index: newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention. Am J Cardiol 78 (1996), 642–646.
23. [23] Romero-Corral, A., Montori, V.M., Somers, V.K., Korinek, J., Thomas, R.J., Allison, T.G., et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368 (2006), 666–678.
24. [24] Barba, R., Marco, J., Ruiz, J., Canora, J., Hinojosa, J., Plaza, S., et al. The obesity paradox in stroke: impact on mortality and short-term readmission. J Stroke Cerebrovasc Dis 24 (2015), 766–770.
25. [25] Gruberg, L., Weissman, N.J., Waksman, R., Fuchs, S., Deible, R., Pinnow, E.E., et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox?. J Am Coll Cardiol 39 (2002), 578–584.
26. [26] Chan, W.C., Koelmeyer, T., Polysarcia adiposa: morbid obesity. Am J Forensic Med Pathol 28 (2007), 249–254.
27. [27] Rastogi, P., Pinto, D.S., Pai, M.R., Kanchan, T., An autopsy study of coronary atherosclerosis and its relation to anthropometric measurements/indices of overweight and obesity in men. J Forensic Leg Med 19 (2012), 12–17.
28. [28] Kortelainen, M.L., Myocardial infarction and coronary pathology in severely obese people examined at autopsy. Int J Obes Relat Metab Disord 26 (2002), 73–79.
29. [29] Warnes, C.A., Roberts, W.C., The heart in massive (more than 300 pounds or 136 kilograms) obesity: analysis of 12 patients studied at necropsy. Am J Cardiol 54 (1984), 1087–1091.
30. [30] Wohlfahrt, P., Somers, V.K., Cifkova, R., Filipovsky, J., Seidlerova, J., Krajcoviechova, A., et al. Relationship between measures of central and general adiposity with aortic stiffness in the general population. Atherosclerosis 235 (2014), 625–631.
31. [31] Golledge, J., Jayalath, R., Oliver, L., Parr, A., Schurgers, L., Clancy, P., Relationship between CT anthropometric measurements, adipokines and abdominal aortic calcification. Atherosclerosis 197 (2008), 428–434.
32. [32] Lehman, S.J., Massaro, J.M., Schlett, C.L., O'Donnell, C.J., Hoffmann, U., Fox, C.S., Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham heart study. Atherosclerosis 210 (2010), 656–661.
33. [33] Stalls, C.M., Triplette, M.A., Viera, A.J., Pathman, D.E., Cohen, M.G., Rossi, J.S., The association between body mass index and coronary artery disease severity: a comparison of black and white patients. Am Heart J 167 (2014), 514–520.
34. [34] McGill, H.C., McMahan, C.A., Herderick, E.E., Zieske, A.W., Malcom, G.T., Tracy, R.E., et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 105 (2002), 2712–2718.
35. [35] Kortelainen, M.L., Porvari, K., Extreme obesity and associated cardiovascular disease verified at autopsy: time trends over 3 decades. Am J Forensic Med Pathol 32 (2011), 372–377.
36. [36] Habbu, A., Lakkis, N.M., Dokainish, H., The obesity paradox: fact or fiction?. Am J Cardiol 98 (2006), 944–948.
37. [37] Ravnskov, U., Is atherosclerosis caused by high cholesterol?. QJM 95 (2002), 397–403.
38. [38] Benagiano, M., Munari, F., Ciervo, A., Amedei, A., Paccani, S.R., Mancini, F., et al. Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis. Proc Natl Acad Sci U S A 109 (2012), 1222–1227.
39. [39] Galkina, E., Ley, K., Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol 27 (2009), 165–197.
40. [40] Ravnskov, U., McCully, K.S., Infections may be causal in the pathogenesis of atherosclerosis. Am J Med Sci 344 (2012), 391–394.